Specnuezhenide Alleviates Senile Osteoporosis by Activating TGR5/FXR Signaling in Bone Marrow Mesenchymal Stem Cells and RANKL-Induced Osteoclasts DOI Creative Commons

Xuehui Deng,

Bingfeng Lin, Wenlong Xiao

и другие.

Drug Design Development and Therapy, Год журнала: 2025, Номер Volume 19, С. 1595 - 1608

Опубликована: Март 1, 2025

Specnuezhenide (SPN) is an iridoid glycoside isolated from Fructus Ligustri Lucidi, herb prescribed for the treatment of senile osteoporosis. However, direct role SPN on bone metabolism remains unclear. In this study, effects d-galactose (d-gal)-induced mice, marrow mesenchymal stem cells (BMSCs), and nuclear factor-κB ligand-induced osteoclasts were examined. Micro-computed tomography was used to observe microstructure. Osteogenesis examined using Western blotting alkaline phosphatase staining. Osteoclastogenesis F-actin ring Senescence-associated β-galactosidase detect cell senescence. addition, expression Takeda G protein-coupled receptor 5 (TGR5)/farnesoid X (FXR) signaling pathway-related genes proteins determined through quantitative real-time polymerase chain reaction immunofluorescence. Oral administration improved microstructure in d-gal-induced mice increased mineral density, volume, trabecular thickness, number. also upregulated osteogenesis markers osteocalcin, morphogenetic protein 2, runt-related transcription factor 2 downregulated osteoclasis tartrate-resistant acid phosphatase, factor-κB, activated T-cells bone. Furthermore, staining, inhibited formation, reduced activity senescence-associated vitro. Mechanistically, TGR5/FXR pathway BMSCs osteoclasts. The protective abolished after addition TGR5 inhibitor SBI-115 or FXR DY268. Moreover, could elevate mRNA levels TGR5, FXR, downstream small heterodimer partner alleviated osteoporosis senescence by activating pathway.

Язык: Английский

Application of stem cells in regeneration medicine DOI Creative Commons
Ye Jin, Shuangyang Li,

Qixuan Yu

и другие.

MedComm, Год журнала: 2023, Номер 4(4)

Опубликована: Июнь 17, 2023

Abstract Regeneration is a complex process affected by many elements independent or combined, including inflammation, proliferation, and tissue remodeling. Stem cells class of primitive with the potentiality differentiation, regenerate self‐replication, multidirectional immunomodulatory functions. their cytokines not only inextricably linked to regeneration ectodermal skin tissues, but also can be used for treatment variety chronic wounds. produce exosomes in paracrine manner. cell play an important role regeneration, repair, accelerated wound healing, biological properties which are similar stem cells, while safer more effective. Skin bone tissues critical organs body, essential sustaining life activities. The weak repairing ability leads pronounced impact on quality patients, could alleviated treatment. However, there obstacles that trough improved bioavailability. This paper summarizes applications mechanisms healing. We propose new ways utilizing through different nanoformulations, liposomes nanoliposomes, polymer micelles, microspheres, hydrogels, scaffold microneedles, improve use healing regeneration.

Язык: Английский

Процитировано

57

The role and applications of extracellular vesicles in osteoporosis DOI Creative Commons
Fei Fang, Jie Yang, Jiahe Wang

и другие.

Bone Research, Год журнала: 2024, Номер 12(1)

Опубликована: Янв. 23, 2024

Abstract Osteoporosis is a widely observed condition characterized by the systemic deterioration of bone mass and microarchitecture, which increases patient susceptibility to fragile fractures. The intricate mechanisms governing homeostasis are substantially impacted extracellular vesicles (EVs), play crucial roles in both pathological physiological contexts. EVs derived from various sources exert distinct effects on osteoporosis. Specifically, released osteoblasts, endothelial cells, myocytes, mesenchymal stem cells contribute formation due their unique cargo proteins, miRNAs, cytokines. Conversely, secreted osteoclasts immune promote resorption inhibit formation. Furthermore, use as therapeutic modalities or biomaterials for diagnosing managing osteoporosis promising. Here, we review current understanding impact homeostasis, including classification biogenesis regulatory present an overview latest research progress treating using EVs. Finally, discuss challenges prospects translational

Язык: Английский

Процитировано

27

Synthetic biology‐based bacterial extracellular vesicles displaying BMP‐2 and CXCR4 to ameliorate osteoporosis DOI Creative Commons
Han Liu,

Peiran Song,

Hao Zhang

и другие.

Journal of Extracellular Vesicles, Год журнала: 2024, Номер 13(4)

Опубликована: Апрель 1, 2024

Osteoporosis (OP) is a systematic bone disease characterized by low mass and fragile microarchitecture. Conventional treatment for OP has limited efficacy long-term toxicity. Synthetic biology makes bacterial extracellular vesicle (BEVs)-based therapeutic strategies promising alternative the of OP. Here, we constructed recombinant probiotics Escherichia coli Nissle 1917-pET28a-ClyA-BMP-2-CXCR4 (ECN-pClyA-BMP-2-CXCR4), in which BMP-2 CXCR4 were overexpressed fusion with BEVs surface protein ClyA. Subsequently, isolated engineered BEVs-BMP-2-CXCR4 (BEVs-BC) therapy. The BEVs-BC exhibited great targeting vivo. In addition, had good biocompatibility remarkable ability to promote osteogenic differentiation BMSCs. Finally, synthetic biology-based significantly prevented an ovariectomized (OVX) mouse model. conclusion, both bone-targeting bone-forming one-step using biology, provides effective strategy potential industrialization.

Язык: Английский

Процитировано

27

Silk Fibroin-Platelet Rich Plasma Injectable Hydrogel with Controlled-Release of Growth Factors for Knee Osteoarthritis DOI
Suvinai Jiraboonsri,

Jirasak Jitpibull,

Thun Itthipanichpong

и другие.

Journal of Drug Delivery Science and Technology, Год журнала: 2025, Номер unknown, С. 106625 - 106625

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

2

Exosomes from young plasma alleviate osteoporosis through miR-217-5p-regulated osteogenesis of bone marrow mesenchymal stem cell DOI
Fanying Meng, Guangchao Wang,

Fengjin Zhou

и другие.

Composites Part B Engineering, Год журнала: 2024, Номер 276, С. 111358 - 111358

Опубликована: Март 4, 2024

Язык: Английский

Процитировано

13

Bone-organ axes: bidirectional crosstalk DOI Creative Commons

An-Fu Deng,

Fuxiao Wang, Sicheng Wang

и другие.

Military Medical Research, Год журнала: 2024, Номер 11(1)

Опубликована: Июнь 12, 2024

Abstract In addition to its recognized role in providing structural support, bone plays a crucial maintaining the functionality and balance of various organs by secreting specific cytokines (also known as osteokines). This reciprocal influence extends these modulating homeostasis development, although this aspect has yet be systematically reviewed. review aims elucidate bidirectional crosstalk, with particular focus on osteokines. Additionally, it presents unique compilation evidence highlighting critical function extracellular vesicles (EVs) within bone-organ axes for first time. Moreover, explores implications crosstalk designing implementing bone-on-chips assembloids, underscoring importance comprehending interactions advancing physiologically relevant vitro models. Consequently, establishes robust theoretical foundation preventing, diagnosing, treating diseases related axis from perspective cytokines, EVs, hormones, metabolites.

Язык: Английский

Процитировано

13

Multifunctional hydrogel-based engineered extracellular vesicles delivery for complicated wound healing DOI Creative Commons
Zuhao Li,

Jinlong Liu,

Jian Song

и другие.

Theranostics, Год журнала: 2024, Номер 14(11), С. 4198 - 4217

Опубликована: Янв. 1, 2024

The utilization of extracellular vesicles (EVs) in wound healing has been well-documented.However, the direct administration free EVs via subcutaneous injection at sites may result rapid dissipation bioactive components and diminished therapeutic efficacy.Functionalized hydrogels provide effective protection, as well ensure sustained release bioactivity during process, making them an ideal candidate material for delivering EVs.In this review, we introduce mechanisms by which accelerate healing, then elaborate on construction strategies engineered EVs.Subsequently, discuss synthesis application delivery systems to enhance complicated healing.Furthermore, face wounds, functionalized with specific microenvironment regulation capabilities, such antimicrobial, anti-inflammatory, immune regulation, used loading EVs, potential approaches addressing these challenges.Ultimately, deliberate future trajectories outlooks, offering a fresh viewpoint advancement artificial intelligence (AI)-energized materials 3D bio-printed multifunctional hydrogel-based dressings biomedical applications.

Язык: Английский

Процитировано

13

Gut microbially produced tryptophan metabolite melatonin ameliorates osteoporosis via modulating SCFA and TMAO metabolism DOI
Yueqi Chen, Chuan Yang,

Zihan Deng

и другие.

Journal of Pineal Research, Год журнала: 2024, Номер 76(3)

Опубликована: Апрель 1, 2024

Abstract Osteoporosis (OP) is a severe global health issue that has significant implications for productivity and human lifespan. Gut microbiota dysbiosis been demonstrated to be closely associated with OP progression. Melatonin (MLT) an important endogenous hormone modulates bone metabolism, maintains homeostasis, improves Multiple studies indicated MLT participates in the regulation of intestinal gut barrier function. However, promising effects microbiota‐derived remain unclear. Here, we found resulted tryptophan disorder decreased production MLT, while administration could mitigate OP‐related clinical symptoms reverse dysbiosis, including diversity microbiota, relative abundance many probiotics such as Allobaculum Parasutterella , metabolic function flora amino acid nucleotide energy metabolism. Notably, significantly increased short‐chain fatty acids trimethylamine N‐oxide‐related metabolites. Importantly, modulate dynamic balance M1/M2 macrophages, reduce serum levels pro‐inflammatory cytokines, restore gut‐barrier Taken together, our results highlighted roles microbially derived progression via “gut‐bone” axis SCFA which may provide novel insight into development drug treating OP.

Язык: Английский

Процитировано

10

Mesenchymal stem cell-derived extracellular vesicles: a regulator and carrier for targeting bone-related diseases DOI Creative Commons

Jiandong Tang,

Xiangyu Wang, Xu Lin

и другие.

Cell Death Discovery, Год журнала: 2024, Номер 10(1)

Опубликована: Май 2, 2024

Abstract The escalating threat of bone-related diseases poses a significant challenge to human health. Mesenchymal stem cell (MSC)-derived extracellular vesicles (MSC-EVs), as inherent cell-secreted natural products, have emerged promising treatments for diseases. Leveraging outstanding features such high biocompatibility, low immunogenicity, superior biological barrier penetration, and extended circulating half-life, MSC-EVs serve potent carriers microRNAs (miRNAs), long no-code RNAs (lncRNAs), other biomolecules. These cargo molecules play pivotal roles in orchestrating bone metabolism vascularity through diverse mechanisms, thereby contributing the amelioration Additionally, engineering modifications enhance bone-targeting ability MSC-EVs, mitigating systemic side effects bolstering their clinical translational potential. This review comprehensively explores mechanisms which regulate disease progression. It delves into therapeutic potential adept drug carriers, augmented by engineered modification strategies tailored osteoarthritis (OA), rheumatoid arthritis (RA), osteoporosis, osteosarcoma. In conclusion, exceptional promise exhibited positions them an excellent solution with considerable applications orthopedics.

Язык: Английский

Процитировано

10

The absence of IRG1 exacerbates bone loss in a mouse model of ovariectomy‐induced osteoporosis by increasing osteoclastogenesis through the potentiation of NLRP3 inflammasome activation DOI
Fang Wang,

Yanqiao Liu,

Yanqin Zhao

и другие.

International Immunopharmacology, Год журнала: 2025, Номер 148, С. 114099 - 114099

Опубликована: Янв. 26, 2025

Язык: Английский

Процитировано

1